Pfizer Values Standalone Consumer Unit At $10 Bil.
This article was originally published in The Rose Sheet
Executive Summary
Pfizer is unlikely to divest individual brands from its Consumer Healthcare portfolio, leaving on the table the options of cashing out, spinning off or keeping the division, CEO Hank McKinnell indicated during a Feb. 10 analyst presentation
You may also be interested in...
J&J Acquires Listerine, Lubriderm As Part Of $16.6 Bil. Pfizer Deal
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare augments the company's oral care division into a billion dollar-plus business and expands the segment's global reach, the company said
J&J Acquires Listerine, Lubriderm As Part Of $16.6 Bil. Pfizer Deal
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare augments the company's oral care division into a billion dollar-plus business and expands the segment's global reach, the company said
Colgate Eyes Opportunities In “Multi-Benefit” Oral Care Segment
Colgate-Palmolive sees opportunities for growth in the "multi-benefit" oral care market in the U.S., President Global Oral Care Nigel Burton stated during a June 12 Deutsche Bank Global Consumer & Food Retail Conference in Paris